A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Novartis
Massachusetts General Hospital
Duke University
Roswell Park Cancer Institute
Westat
Hospital Universitari Vall d'Hebron Research Institute
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
University of California, San Francisco
Baylor College of Medicine
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)